RxSight Inc (NAS:RXST)
$ 4.95 -0.14 (-2.85%) Market Cap: 204.91 Mil Enterprise Value: -2.14 Mil PE Ratio: 0 PB Ratio: 0.77 GF Score: 68/100

Q1 2025 Rxsight Inc Earnings Call Transcript

May 7, 2025 / 08:30 PM GMT
Release Date Price: $14.9 (+6.81%)

Key Points

Positve
  • RxSight Inc (RXST) reported a 28% increase in revenue for Q1 2025 compared to the same quarter in 2024, reaching $37.9 million.
  • The company achieved a gross margin of 74.8% in Q1 2025, up from 70.1% in Q1 2024, primarily due to lower LAL costs and product mix.
  • RxSight Inc (RXST) is ahead of schedule in launching a software update that includes new features for LDD procedures, enhancing clinical education and marketing efforts.
  • The company received full regulatory approval for its LAL Plus and LDD products in South Korea, with expectations for UK approval in Q2 2025.
  • RxSight Inc (RXST) maintains a strong cash position with $229.3 million in cash equivalents and short-term investments, supporting its progress toward cash flow break-even.
Negative
  • The company experienced its first year-over-year drop in the LAL's per LDD metric due to macroeconomic headwinds and competitive disruptions.
  • There was a 6% decline in revenue compared to Q4 2024, indicating a sequential slowdown.
  • SG&A expenses increased by 23% year-over-year, driven by higher personnel costs and stock-based compensation.
  • R&D expenses rose by 29% compared to Q1 2024, primarily due to increased salaries and stock-based compensation.
  • The company reported a GAAP net loss of $8.2 million for Q1 2025, although this was an improvement from the $9.1 million loss in Q1 2024.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RXST.OQ - Rxsight Inc
Q1 2025 Rxsight Inc Earnings Call
May 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. At this time, I would like to welcome everyone to the RX site first quarter 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star, followed by the number one on your telephone keypad.

If you would like to withdraw your question, press t one again. I would not like to turn the conference over to Oliver Morachevich, Vice President of Investor relations. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot